| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ad66884a6f2a66126d492e56e09be39 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-775
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate |
1990-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a60e3efa5289729c6b9954724417b34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b85e9709bbd0273144a65e9921f2882 |
| publicationDate |
1991-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9102524-A1 |
| titleOfInvention |
Use of the (+)-enantiomer of anipamil |
| abstract |
Described is the use of the (+)-enantiomer of anipamil, and its salts with physiologically tolerable acids, in the preparation of drugs with anti-arteriosclerotic properties. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1022025-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1013275-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6548082-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1013275-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1022025-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6649183-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11642285-B2 |
| priorityDate |
1989-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |